MAGNI, FULVIO
 Distribuzione geografica
Continente #
NA - Nord America 19.909
EU - Europa 10.393
AS - Asia 3.424
SA - Sud America 40
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 12
AF - Africa 11
Totale 33.812
Nazione #
US - Stati Uniti d'America 19.440
IT - Italia 2.363
DE - Germania 1.782
SE - Svezia 1.598
IE - Irlanda 1.558
CN - Cina 1.524
SG - Singapore 936
UA - Ucraina 815
RU - Federazione Russa 576
GB - Regno Unito 541
CA - Canada 454
HK - Hong Kong 440
AT - Austria 316
FI - Finlandia 230
VN - Vietnam 182
FR - Francia 158
DK - Danimarca 121
IN - India 115
NL - Olanda 86
BE - Belgio 79
TR - Turchia 72
JP - Giappone 37
ID - Indonesia 32
CZ - Repubblica Ceca 26
PL - Polonia 25
BR - Brasile 24
IR - Iran 21
RO - Romania 21
ES - Italia 20
EU - Europa 20
BG - Bulgaria 19
CH - Svizzera 16
KR - Corea 15
TW - Taiwan 14
GR - Grecia 13
MX - Messico 12
NO - Norvegia 11
AU - Australia 9
CL - Cile 6
IL - Israele 6
PT - Portogallo 6
TH - Thailandia 6
AR - Argentina 4
MY - Malesia 4
PH - Filippine 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EC - Ecuador 3
LU - Lussemburgo 3
MT - Malta 3
NZ - Nuova Zelanda 3
PE - Perù 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
DZ - Algeria 2
HR - Croazia 2
MA - Marocco 2
MU - Mauritius 2
SC - Seychelles 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
BT - Bhutan 1
DO - Repubblica Dominicana 1
EG - Egitto 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
PA - Panama 1
PK - Pakistan 1
PR - Porto Rico 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
Totale 33.812
Città #
Ann Arbor 4.346
Woodbridge 1.851
Fairfield 1.644
Chandler 1.520
Dublin 1.514
Houston 1.220
Frankfurt am Main 1.089
Wilmington 1.013
Ashburn 987
Jacksonville 871
Milan 848
Dearborn 742
Singapore 732
Seattle 670
New York 584
Cambridge 549
Princeton 456
Hong Kong 429
Vienna 307
Nanjing 295
Shanghai 295
Altamura 181
Lawrence 175
Santa Clara 165
Beijing 154
Lachine 143
Montréal 142
Dong Ket 127
Nanchang 115
Fremont 100
Guangzhou 81
Andover 77
Helsinki 76
San Diego 76
Brussels 71
Shenyang 69
Ottawa 68
Toronto 67
Hebei 66
Los Angeles 60
Boardman 59
London 51
Tianjin 48
Changsha 47
Lissone 45
Jiaxing 43
Jinan 41
Chicago 40
Falls Church 38
Rome 38
Huizen 37
Zhengzhou 36
Florence 35
Mountain View 34
Norwalk 34
Jakarta 32
Nürnberg 32
Caronno Pertusella 31
Ningbo 30
Kunming 28
Pune 27
Auburn Hills 25
Brescia 25
Washington 25
Cinisello Balsamo 24
Edmonton 23
Monza 23
Dallas 21
Brno 20
Pavia 20
Munich 19
San Mateo 19
Detroit 18
Kiev 18
Bonndorf 17
Hefei 17
Plovdiv 17
Hangzhou 16
Kilburn 16
Napoli 16
Sacramento 16
Taizhou 16
University Park 16
Carate Brianza 15
Sesto San Giovanni 15
Kocaeli 14
Madison 14
Melzo 14
Ripalta Cremasca 14
Padova 12
San Giuliano Milanese 12
São Paulo 12
Bergamo 11
Cagliari 11
Centro Municipality 11
Naples 11
Phoenix 11
Turin 11
Verona 11
Kraków 10
Totale 25.417
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 418
Comparative membrane proteomics: A technical advancement in the search of renal cell carcinoma biomarkers 353
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 343
Respiratory metabolism and calorie restriction relieve persistent endoplasmic reticulum stress induced by calcium shortage in yeast 329
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 328
Differential protein profiling of renal cell carcinoma urinary exosomes 317
11C-Labelling of N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide Derivatives and Evaluation as Potential Radioligands for PET imaging of Dopamine D3 Receptors 301
MALDI imaging in Fabry nephropathy: a multicenter study 294
Urinary exosomes and diabetic nephropathy: a proteomic approach 289
Urinary proteomics for the study of genetic kidney diseases 274
Effects of Hematuria on the Proteomic Profile of Urinary Extracellular Vesicles: Technical Challenges 268
The PAF-acether receptor antagonist BN-52021 inhibits mediator release during guinea-pig active lung anaphylaxis 266
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 266
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 262
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 260
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 259
Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 253
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 253
Serum biomarkers of Renal Cell Carcinoma assessed using a protein profiling approach based on ClinProt technique 252
11C-radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]Zofenoprilat 251
The proteomic landscape of renal tumors 241
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 241
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 235
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 231
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 230
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 229
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 229
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 227
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 223
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 223
The putative role of MALDI-MSI in the study of Membranous Nephropathy 222
Mutual Information Optimization for Mass Spectra Data Alignment 222
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 222
Robust conclusions in mass spectrometry analysis 221
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 218
Expression of heat shock protein 27 in human renal cell carcinoma 214
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 214
Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing 211
Different expression of Fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathy 210
3D bioprinted colorectal cancer models based on hyaluronic acid and signalling glycans 209
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 209
Improved synthesis and radiolabeling of [C-11]MP4A, a suitable ligand for the investigation of the cholinergic system using PET 204
Proteomics for the study of new biomarkers in Fabry disease: State of the art 203
Proteomics for the diagnosis of thyroid lesions: Preliminary report 202
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 202
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 201
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 200
Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients 198
Tumor size, stage and grade alterations of urinary peptidome in RCC 198
Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3 197
Urinary extracellular vesicles and salt-losing tubulopathies: A proteomic approach 195
Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors 193
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 193
Proteome analysis in thyroid pathology 190
A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: Application to RCC urinary exosomes 187
Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery 185
Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging 185
Analysis of correlation structures in renal cell carcinoma patient data 182
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 178
Cholinergic ligand [C-11]MP4A: Improved 4-acetoxypiperidine precursor synthesis via LC-APCI/MS characterisation and improved radioligand HPLC purification 177
Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples 177
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 176
Human urine biomarkers of renal cell carcinoma evaluated by ClinProt 175
Radiosynthesis of [123I]βCIT, a selective ligand for the study of the dopaminergic and serotoninergic systems in human brain 175
Characterization of heat shock protein 27 phosphorylation sites in renal cell carcinoma 173
An Alternative Approach in Endocrine Pathology Research: MALDI-IMS in Papillary Thyroid Carcinoma 173
[11C]RN5: A new agent for the in vivo imaging of myocardial α1-adrenoceptors 172
Imaging mass spectrometry: a new tool for kidney disease investigations 171
HNE-Abeta adducts evaluated in vitro and in washed platelets by HPLC-ESI-MS 165
Enzymatic synthesis of [methyl-2H3] creatinine 165
Diabetes-induced alteration of HMGCoA reductase forms in rat livers 165
Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET 163
1H NMR analysis of isocyclosporin A prepared in organic solvent and in aqueous solution 163
MALDI-MSI analysis of cytological smears: The study of thyroid cancer 163
A Mutual Information Approach to Data Integration for Alzheimer’s Disease Patients 161
Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach 161
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 161
Differential expression of AQP1 in microdomain-enriched membranes of Renal Cell Carcinoma 160
1st National Congress of the Italian Proteome Society 160
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE 159
Asymmetric synthesis and preliminary evaluation of (R)- and (S)-[11C]bisoprolol, a putative beta1-selective adrenoceptor radioligand 158
Sensitive GC-MS method for the determination of specific-activity of 16a[18F]Fluoro-estra-1,3,5(10)-triene-3,17b-diol 158
Proteomic knowledge of human aquaporins 155
Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues 155
The urinary proteome and peptidome of renal cell carcinoma patients: A comparison of different techniques 153
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 153
Mutations of the CK2 phosphorylation site of Sic1 affect cell size and S-Cdk kinase activity in Saccharomyces cerevisiae 152
A Support Vector Machine Classification of Thyroid Bioptic Specimens Using MALDI-MSI Data 152
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 152
Intraluminal proteome and peptidome of human urinary extracellular vesicles 151
Synthesis and in vivo evaluation of [C-11]CGP62349, a new GABA(B) receptor antagonist 150
Comparative proteomics of membrane microdomains from renal cell carcinoma and adiacent normal kidney 149
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 149
Renal cell carcinoma primary cultures maintain genomic and phenotypic profile of parental tumor tissues 148
Applying Random Graphs for Proteomic Data Analysis of RCC Patients 148
The continuous low dose insulin and glucose infusion test: a simplified and accurate method for the evaluation of insulin sensitivity and insulin secretion in population studies 147
Detection of high molecular weight proteins by MALDI imaging mass spectrometry 147
Towards the standardization of mitochondrial proteomics: the Italian mt-HPP initiative 147
A molecular imaging approach to individuate tumour infiltrating lymphocytes 147
Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis 146
Totale 20.542
Categoria #
all - tutte 111.311
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.311


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.949 0 0 440 458 558 734 892 423 560 346 390 148
2020/20215.044 282 242 520 592 447 406 535 462 387 468 260 443
2021/20223.272 261 295 307 415 200 267 119 192 156 244 282 534
2022/20236.033 670 1.860 485 603 352 860 72 375 380 62 183 131
2023/20244.723 138 155 192 320 515 1.359 988 125 295 76 121 439
2024/20251.859 470 925 464 0 0 0 0 0 0 0 0 0
Totale 35.019